Case Reports
doi: 10.1097/RLU.0000000000004390.
Epub 2022 Sep 6.
64Cu-DOTATATE Uptake in a Pulmonary Hamartoma
Affiliations
- PMID: 36469060
- DOI: 10.1097/RLU.0000000000004390
Item in Clipboard
Case Reports
64Cu-DOTATATE Uptake in a Pulmonary Hamartoma
Clin Nucl Med.
.
Abstract
DOTATATE PET/CT is frequently used to evaluate indeterminant pulmonary nodules suspected to be pulmonary carcinoid. We report an unexpected case of pulmonary hamartoma demonstrating 64Cu-DOTATATE uptake in a 43-year-old woman with a slowly enlarging pulmonary nodule. Histopathological staining showed somatostatin receptor 2 expression on vascular endothelial cells and a proportion of cartilage and smooth muscle cells within the hamartoma.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest and sources of funding: none declared.
Similar articles
-
A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.J Nucl Med. 2009 Dec;50(12):1927-32. doi: 10.2967/jnumed.109.066639. Epub 2009 Nov 12. J Nucl Med. 2009. PMID: 19910422
-
Diagnosis and Treatment of Lung Neuroendocrine Neoplasms: Somatostatin Receptor PET Imaging and Peptide Receptor Radionuclide Therapy.PET Clin. 2023 Apr;18(2):223-231. doi: 10.1016/j.cpet.2022.11.005. Epub 2022 Dec 28. PET Clin. 2023. PMID: 36585338 Review.
-
Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.Clin Nucl Med. 2014 Jun;39(6):505-10. doi: 10.1097/RLU.0000000000000429. Clin Nucl Med. 2014. PMID: 24662668
-
Correlation and Comparison of Somatostatin Receptor Type 2 Immunohistochemical Scoring Systems with 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.Neuroendocrinology. 2022;112(4):358-369. doi: 10.1159/000517530. Epub 2021 Jun 2. Neuroendocrinology. 2022. PMID: 34077939
-
Gastro-Entero-Pancreatic Tumors: FDG Positron Emission Tomography/Computed Tomography.PET Clin. 2023 Apr;18(2):243-250. doi: 10.1016/j.cpet.2022.11.007. Epub 2023 Jan 25. PET Clin. 2023. PMID: 36707371 Review.
Cited by
-
Epigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy.Epigenetics Chromatin. 2024 Oct 16;17(1):31. doi: 10.1186/s13072-024-00554-6. Epigenetics Chromatin. 2024. PMID: 39415281 Free PMC article. Review.
-
Recent Advances in 64Cu/67Cu-Based Radiopharmaceuticals.Int J Mol Sci. 2023 May 23;24(11):9154. doi: 10.3390/ijms24119154. Int J Mol Sci. 2023. PMID: 37298101 Free PMC article. Review.
References
-
- Delpassand ES, Ranganathan D, Wagh N, et al. 64 Cu-DOTATATE PET/CT for imaging patients with known or suspected somatostatin receptor-positive neuroendocrine tumors: results of the first U.S. Prospective, Reader-Masked Clinical Trial. J Nucl Med . 2020;61:890–896.
-
- Johnbeck CB, Knigge U, Loft A, et al. Head-to-head comparison of 64 Cu-DOTATATE and 68 Ga-DOTATOC PET/CT: a prospective study of 59 patients with neuroendocrine tumors. J Nucl Med . 2017;58:451–457.
-
- Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68 Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics . 2015;35:500–516.
-
- Itaya Yamaga LY, Wagner J, Buarque de Gusmão Funari M. 68 Ga-DOTATATE PET/CT in nonneuroendocrine tumors: a pictorial essay. Clin Nucl Med . 2017;42:e313–e316.
-
- Kumar A, Jindal T, Dutta R, et al. Functional imaging in differentiating bronchial masses: an initial experience with a combination of (18)F-FDG PET-CT scan and (68)Ga DOTA-TOC PET-CT scan. Ann Nucl Med . 2009;23:745–751.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
